ACCEPTABILITY AND DISCONTINUATION OF INTRA UTERINE CONTRACEPTIVE DEVICE - A FOLLOW UP STUDY AT SECONDARY CARE HOSPITAL
Introduction: Intrauterine devices are increasingly used as a method of family planning, but satisfaction of women who have adopted intrauterine device need further characterization. Our specific aims were to review systematically women who accepted IUD 380-A as post partum IUD , following MTP or IUD only, their experience, satisfaction and complications with this choice of contraception.
Material and Methods: We studied 272 women who came for follow up of cu-t 380 –A, in the Gynaecology OPD of hospital of Delhi government from January 2013 to February 2015. We assessed their acceptance with continuation, complication & rejection of cu-t 380 –A.
Results: Maximum patients were in the age group of 20-24 years. 79% patients continuing with IUD, while 10.2% experienced the complications. 21% visited for removal of IUD with most frequent reason being prolonged bleeding.
Conclusion: Women who received cu-t 380 –A show a high level of satisfaction with this choice of contraception and the rates of expulsion were low enough such that the benefit of contraceptive protection outweigh the potential inconvenience of needing to return for care in that subset of women.
ACOG Practice Bulletin No. 121. (2011). “Long-acting reversible contraception: Implants and intrauterine devices”, Obstet Gynecol, Jul, Vol.118(1), pp.184-196, accessed online: http://reference.medscape.com/medline/abstract/21691183
Andersson K, Batar I, and Rybo G. (1992). “Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T”, Contraception, Dec, Vol.46(6), pp.575-584, available online: http://reference.medscape.com/medline/abstract/1493717
Andersson K, Odlind V, and Rybo G. (1994). “Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial”, Contraception, Vol.49, pp.56-72.
Brockmeyer A, Kishen M, and Webb A. (2008). “Experience of IUD/IUS insertions and clinical performance in nulliparous women—a pilot study”, Eur J Contracept Reprod Health Care, Vol.13, pp.248-254.
CDCP. (2010). “US Medical Eligibility Criteria for Contraceptive Use”, MMWR Recomm Rep: Centers for Disease Control and Prevention, pp.591-686.
Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, and Creinin MD. (2010). “Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial”, Obstet Gynecol, Nov, Vol.116(5), pp.1079-1087.
Cheng L, Gulmezoglu AM, Piaggio GG, Ezcurra EE, and Van Look PP. (2008). “Interventions for emergency contraception”, Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD001324, DOI: 10.1002/14651858.CD001324.pub3
Hatcher RA, Trussell J, Nelson AL, Cates W Jr, Stewart F, and Kowal D. (editors). (2007). “Contraceptive technology”. Vol.19th, Revised edition, Ardent Media, New York, NY.
Hubacher D. (2007). “Copper intrauterine device use by nulliparous women: review of side effects”, Contraception, Vol.75(6 suppl), pp.S8–S11.
Hubacher D, and Grimes DA. (2002). “Noncontraceptive Health Benefits of Intrauterine Devices: A Systematic Review”, Obstetrical & Gynecological Survey, February, Vol.57(2), pp.120-128.
IMAP. (2003). “International Medical Advisory Panel Statement of Intrauterine Devices”, IPPF Medical Bulletin: Internaltion Medical Advisory Panel, Vol.37, pp.1-4.
Oster G, and Salgo MP. (1975). “The copper intrauterine device and its mode of action”, New England Journal of Medicine, August 20, Vol.293(9), pp.432-438.
Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, and Eisenberg D, et al. (2011). “Continuation and satisfaction of reversible contraception”, Obstet Gynecol, May, Vol.117(5), pp.1105-1113, available online: http://reference.medscape.com/medline/abstract/21508749
Rivera R, Yacobson I, and Grimes D. (1999). “The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices”, Am J Obstet Gynecol, Vol.181, pp.1263-1269. (Level III)
Stanford JB, and Mikolajczyk RT. (2002). “Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects”, Am J Obstet Gynecol, Vol.187, pp.1699–708. (Level III)
Trussell J. (2010). “Medical eligibility criteria for contraceptive use”, 4th edition, WHO Press, Geneva, Switzerland, ISBN: 9789241563888, 125 pages, Hum Fertil (Camb). Sep 2011;14(3):203, available online: http://reference.medscape.com/medline/abstract/21870993
- There are currently no refbacks.
Send mail to firstname.lastname@example.org with questions or comments about this web site.
International Journal of Medical and Pharma Research, All rights reserved.